What is the extent of impact of generic products in Japan? Also, what kinds of countermeasure to generic drugs are there?
A6. The format for prescriptions changed starting this April, and since it has been only a month, we cannot make any statements. Also, the national policy is to actively promote the use of generic drugs, and we cannot fight national policy. Prescription drug companies will supply a level and quality of information that generic drug companies cannot perform. For example, we supply information such as mega-studies on Mevalotin, which is something that generic drug companies can in no way do.
